Therefore, the purpose of this study was to determine the incidence of and the risk factors for depression in patients with Graves’ disease who developed SCH after 131I treatment, and to evaluate the therapeutic effect of thyroid hormone replacement in these patients. The gene discussed is TG; the disease is major depressive disorder.